Pepdox
Studies
Peptides
Calculator
In response: Considerations regarding compounding pharmacies and GLP-1 agonists. | Pepdox
Home
/
Search
/
PMID 38600000
In response: Considerations regarding compounding pharmacies and GLP-1 agonists.
The American journal of emergency medicine
2024
PMID: 38600000
View on PubMed
DOI: 10.1016/j.ajem.2024.03.037
Semaglutide
Authors
Long, Brit; Pelletier, Jessica; Koyfman, Alex; Bridwell, Rachel E
Keywords
Adverse event
Complication
Compounding
Diabetes
Endocrine
GLP-1 agonist
Liraglutide
Semaglutide
Side effect
Weight loss